Hologic Inc reports results for the quarter ended March 31 - Earnings Summary

Hologic

02/05/2025 04:21

Hologic Inc HOLX.OQ reported quarterly adjusted earnings of $1.03​​ per share for the quarter ended March 31, identical to the same quarter last year.  The mean expectation of eighteen analysts for the quarter was for earnings of $1.02 per share. Wall Street expected results to range from $1.00  to $1.03 per share.

Revenue fell 1.2% to $1.01 billion from a year ago; analysts expected $1.00 billion.

Hologic Inc's reported EPS for the quarter was a loss of 8 cents​.

The company reported a quarterly loss of $17.4 million.

Hologic Inc shares had fallen by 5.8% this quarter and lost 19.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 2.7% in the last three months.​

In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy," 15 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for Hologic Inc is $75.00

This summary was machine generated from LSEG data May 2 at 03:20 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
1.02
1.03
Beat
Dec. 31 2024
1.02
1.03
Beat
Sep. 30 2024
1.01
1.01
Met
Jun. 30 2024
1.02
1.06
Beat